Vimarsana
Biggest News Aggregation in the World

Page 2 - Pharma Srl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Srl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Srl Today - Breaking & Trending Today

Global Inspection Machines Market Report to 2027: Increasing Pharmaceutical & Biotechnology R&D Expenditure Drives Growth - Vimarsana News

Global Inspection Machines Market Report to 2027: Increasing Pharmaceutical & Biotechnology R&D Expenditure Drives Growth

/PRNewswire/ -- The "Inspection Machines Market by Product (Vision Inspection, Leak Detection, X-ray Inspection, Checkweigher, Metal Detector, Software), Type...

TES Pharma Congratulates Intercept Pharmaceuticals on their Presentation of Phase 1 INT-787 Data at the AASLD Meeting and the Initiation of the Phase 2a FRESH Study in Patients with Severe Alcohol-Associated Hepatitis - Vimarsana News

TES Pharma Congratulates Intercept Pharmaceuticals on their Presentation of Phase 1 INT-787 Data at the AASLD Meeting and the Initiation of the Phase 2a FRESH Study in Patients with Severe Alcohol-Associated Hepatitis

INT-787 is a selective next generation FXR agonist invented by TES Pharma and licensed to Intercept Pharmaceuticals INT-787 has shown strong anti-fibrotic and anti-inflammatory effects

Lo.Li. Pharma International: Pervistop, the once-daily supplement specifically designed to manage persistent HPV, is now available for exclusive distribution rights worldwide. - Vimarsana News

Lo.Li. Pharma International: Pervistop, the once-daily supplement specifically designed to manage persistent HPV, is now available for exclusive distribution rights worldwide.

Lo.Li. Pharma International to unveil an innovative new product at CPHI Frankfurt, which has already gained the interest of numerous distribution partners. Pervistop promises to be an extremely

Pervistop®, the once-daily supplement specifically designed to manage persistent HPV, is now available for exclusive distribution rights worldwide. - Vimarsana News

Pervistop®, the once-daily supplement specifically designed to manage persistent HPV, is now available for exclusive distribution rights worldwide.

/PRNewswire/ -- Lo.Li. Pharma International announces the pre-launch of a new, highly anticipated product at CPHI 2022, fulfilling a latent unmet clinical need...